keyword
https://read.qxmd.com/read/38652922/a-non-midline-unclassified-glioneuronal-tumor-with-h3k27m-mutation-enlarging-the-spectrum-of-cns-tumors-h3k27me3-altered
#1
JOURNAL ARTICLE
Oumaima Aboubakr, Suhan Senova, Paul Kauv, David Castel, Yassine Ajlil, Raphael Saffroy, Romain Appay, Alice Métais, Lauren Hasty, Pascale Varlet, Arnault Tauziède-Espariat
No abstract text is available yet for this article.
April 23, 2024: Journal of Neuropathology and Experimental Neurology
https://read.qxmd.com/read/38650572/evaluating-the-predictive-value-of-a-coagulation-related-gene-model-in-glioma
#2
JOURNAL ARTICLE
Ming Cao, Jie Chen, Rong-Zeng Guo
AIM: The prognosis of glioma, which is the most common and malignant tumor in the central nervous system, requires the identification of additional markers. MATERIAL AND METHODS: The mRNA expression and clinical data of glioma were downloaded from the TCGA and CGGA databases. Coagulation-related genes were downloaded from the KEGG database. The expression model was constructed using LASSO regression. The GBM data were divided into high and low-risk expression groups based on the median risk score, and the differences in overall survival and progression-free survival between them were calculated...
December 16, 2023: Turkish Neurosurgery
https://read.qxmd.com/read/38650560/non-detection-of-hcmv-total-genomic-dna-in-human-glioma-cells-genome
#3
JOURNAL ARTICLE
Dilek Gokturk, Meryem Damla Ozdemir, Dervis Mansuri Yilmaz
AIM: Malignant tumors of the central nervous system, called gliomas, are widely known for their rapid progression. They arise from oncogene stimulation and tumor suppressor inhibition, just like in all malignancies. Recent studies have revealed that human cytomegalovirus (HCMV) is involved in the pathogenesis of gliomas; therefore, we aimed at demonstrating if the HCMV genome is part of the genomic DNA of glioma cells or not. MATERIAL AND METHODS: The study included U87MG glioblastoma cell culture and tumor samples from glioma patients...
May 5, 2023: Turkish Neurosurgery
https://read.qxmd.com/read/38650430/prognostic-factors-of-spinal-intramedullary-hemangioblastoma-analysis-of-surgical-outcomes-and-tumor-characteristics
#4
JOURNAL ARTICLE
Hyun Jun Jang, Bong Ju Moon, Kyung Hyun Kim, Jeong Yoon Park, Dong Kyu Chin, Yong Eun Cho, Keun Su Kim
OBJECTIVE: Spinal intramedullary hemangioblastoma is a rare and highly vascularized benign tumor. The characteristics of the tumor, its corresponding location, and surgical outcomes remain unknown. The purpose of this study was to identify risk factors and strategies for neurologic deterioration following hemangioblastoma surgery. METHODS: A comprehensive retrospective analysis was undertaken to evaluate patients who underwent surgical intervention for intramedullary hemangioblastoma at our institution from 1993 to 2022...
April 23, 2024: Journal of Korean Neurosurgical Society
https://read.qxmd.com/read/38650040/clinical-pathologic-and-genomic-characteristics-of-two-pediatric-glioneuronal-tumors-with-a-clip2-met-fusion
#5
JOURNAL ARTICLE
Nicholas Chapman, Joshua Greenwald, Jolee Suddock, Dong Xu, Alexander Markowitz, Maeve Humphrey, Jennifer A Cotter, Mark D Krieger, Debra Hawes, Jianling Ji
Integration of molecular data with histologic, radiologic, and clinical features is imperative for accurate diagnosis of pediatric central nervous system (CNS) tumors. Whole transcriptome RNA sequencing (RNAseq), a genome-wide and non-targeted approach, allows for the detection of novel or rare oncogenic fusion events that contribute to the tumorigenesis of a substantial portion of pediatric low- and high-grade glial and glioneuronal tumors. We present two cases of pediatric glioneuronal tumors occurring in the occipital region with a CLIP2::MET fusion detected by RNAseq...
April 22, 2024: Acta Neuropathologica Communications
https://read.qxmd.com/read/38648267/meningeal-lymphatics-in-central-nervous-system-diseases
#6
REVIEW
Andrea Francesca M Salvador, Nora Abduljawad, Jonathan Kipnis
Since its recent discovery, the meningeal lymphatic system has reshaped our understanding of central nervous system (CNS) fluid exchange, waste clearance, immune cell trafficking, and immune privilege. Meningeal lymphatics have also been demonstrated to functionally modify the outcome of neurological disorders and their responses to treatment, including brain tumors, inflammatory diseases such as multiple sclerosis, CNS injuries, and neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. In this review, we discuss recent evidence of the contribution of meningeal lymphatics to neurological diseases, as well as the available experimental methods for manipulating meningeal lymphatics in these conditions...
April 22, 2024: Annual Review of Neuroscience
https://read.qxmd.com/read/38647646/screening-and-surveillance-recommendations-for-central-nervous-system-hemangioblastomas-in-pediatric-patients-with-von-hippel-lindau-disease
#7
JOURNAL ARTICLE
Anna Laura Knoblauch, B-I Blaß, C Steiert, N Neidert, A Puzik, E Neumann-Haefelin, A Ganner, F Kotsis, T Schäfer, H P H Neumann, S Elsheikh, J Beck, J-H Klingler
PURPOSE: Von Hippel-Lindau (VHL) disease is an autosomal-dominantly inherited tumor predisposition syndrome. One of the most common tumors are central nervous system (CNS) hemangioblastomas. Recommendations on the initiation and continuation of the screening and surveillance program for CNS tumors in pediatric VHL patients are based on small case series and thus low evidence level. To derive more robust screening recommendations, we report on the largest monocentric pediatric cohort of VHL patients...
April 22, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38647018/ultrasmall-iron-oxide-nanoparticles-with-mrgfus-for-enhanced-magnetic-resonance-imaging-of-orthotopic-glioblastoma
#8
JOURNAL ARTICLE
Jingwen Chen, Rui Yang, Hongwei Yu, Hao Wu, Nan Wu, Suhe Wang, Xiaorui Yin, Xiangyang Shi, Han Wang
Ultrasmall iron oxide nanoparticles (USIO NPs) are expected to become the next generation T 1 contrast agents; however, their diagnostic and therapeutic potential for primary brain tumors (such as glioblastoma multiforme, GBM) is yet to be explored. At present, the main challenge is the effective hindering of biological barriers, including the blood-brain barrier (BBB) and the blood-brain tumor barrier (BBTB). Herein, we aimed to investigate whether the USIO NPs, in combination with MR-guided focused ultrasound (MRgFUS), could intensify MR imaging of GBM...
April 22, 2024: Journal of Materials Chemistry. B, Materials for Biology and Medicine
https://read.qxmd.com/read/38645012/transcriptomic-and-proteomic-spatial-profiling-of-pediatric-and-adult-diffuse-midline-glioma-h3-k27-altered-reveals-region-specific-differences-and-limited-overlap-between-mrna-and-protein
#9
Sudarshawn Damodharan, Jack M Shireman, Elliot Xie, Emily Distler, Christina Kendziorski, Mahua Dey
Diffuse midline glioma, H3 K27 -altered (DMG-Alt) are highly aggressive malignancies of the central nervous system (CNS) that primarily affect the pediatric population. Large scale spatial transcriptomic studies have implicated that tumor microenvironmental landscape plays an important role in determining the phenotypic differences in tumor presentation and clinical course, however, data connecting overall transcriptomic changes to the protein level is lacking. The NanoString GeoMx™ Digital Spatial Profiler platform was used to determine the spatial transcriptomic and proteomic landscape in a cohort of both pediatric and adult H3 K27 -altered DMG biopsy samples...
April 5, 2024: Research Square
https://read.qxmd.com/read/38644565/radiotherapy-plus-temozolomide-with-or-without-anlotinib-in-h3k27m-mutant-diffuse-midline-glioma-a-retrospective-cohort-study
#10
JOURNAL ARTICLE
Chao Liu, Shuwen Kuang, Tianxiang Huang, Jun Wu, Longbo Zhang, Xuan Gong
BACKGROUND: Besides the hallmark of H3K27M mutation, aberrant amplifications of receptor tyrosine kinases (RTKs) are commonly observed in diffuse midline glioma (DMG), a highly malignant brain tumor with dismal prognosis. Here, we intended to evaluate the efficacy and safety of a multitarget RTK inhibitor anlotinib in patients with H3K27M-DMG. METHODS: A total of 40 newly diagnosed H3K27M-DMG patients including 15 with anlotinib and 25 without anlotinib treatment were retrospectively enrolled in this cohort...
April 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38644551/usp19-regulates-dna-methylation-damage-repair-and-confers-temozolomide-resistance-through-mgmt-stabilization
#11
JOURNAL ARTICLE
Jiaqi Liu, Kaikai Wang, Qian Zhu, Yixin Zhang, Yuping Chen, Zhenkun Lou, Jian Yuan
OBJECTIVE: To elucidate the relationship between USP19 and O(6)-methylguanine-DNA methyltransferase (MGMT) after temozolomide treatment in glioblastoma (GBM) patients with chemotherapy resistance. METHODS: Screening the deubiquitinase pannel and identifying the deubiquitinase directly interacts with and deubiquitination MGMT. Deubiquitination assay to confirm USP19 deubiquitinates MGMT. The colony formation and tumor growth study in xenograft assess USP19 affects the GBM sensitive to TMZ was performed by T98G, LN18, U251, and U87 cell lines...
April 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38642434/targeting-the-tumor-microenvironment-in-primary-central-nervous-system-lymphoma-implications-for-prognosis
#12
REVIEW
Han Shi, Xuefei Sun, Yuchen Wu, Qu Cui, Shengjun Sun, Nan Ji, Yuanbo Liu
Primary central nervous system lymphoma (PCNSL) is a rare extranodal non-Hodgkin lymphoma, and there is limited research on its tumor microenvironment (TME). Nevertheless, more and more studies have evidence that TME has essential effects on tumor cell proliferation, immune escape, and drug resistance. Thus, it is critical to elucidate the role of TME in PCNSL. The understanding of the PCNSL TME is gradually unfolding, including factors that distinguish it from systemic diffuse large B-cell lymphoma (DLBCL)...
April 19, 2024: Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia
https://read.qxmd.com/read/38642165/nanopore-sequencing-from-formalin-fixed-paraffin-embedded-specimens-for-copy-number-profiling-and-methylation-based-cns-tumor-classification
#13
JOURNAL ARTICLE
Ann-Kristin Afflerbach, Anne Albers, Anton Appelt, Leonille Schweizer, Werner Paulus, Michael Bockmayr, Ulrich Schüller, Christian Thomas
No abstract text is available yet for this article.
April 20, 2024: Acta Neuropathologica
https://read.qxmd.com/read/38642111/central-nervous-system-embryonal-tumor-with-plagl1-amplification-a-case-report-of-a-novel-entity-focusing-on-imaging-findings
#14
JOURNAL ARTICLE
Francisco Maldonado, Ana Filipa Geraldo, Angela Guarnizo, Nicolás Fernández-Ponce, Lorena Baroni, Carlos Rugilo
The embryonal central nervous system (CNS) tumor with PLAGL1 (pleomorphic adenoma gene-like) amplification is a novel type of pediatric neoplasm with a distinct methylation profile, described for the first time in 2022. It may be located anywhere in the neuroaxis and, as its name implies, it is driven by the amplification and overexpression of one of the PLAG family genes. Although the associated clinical, immunohistopathological, and molecular characteristics are well characterized in the seminal report of this entity, data on the radiological features is still lacking...
April 20, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38641945/multi-omics-technologies-and-molecular-biomarkers-in-brain-tumor-related-epilepsy
#15
REVIEW
Yaoqiang Du, Rusong Li, Danqing Fu, Biqin Zhang, Ailin Cui, Yutian Shao, Zeyu Lai, Rongrong Chen, Bingyu Chen, Zhen Wang, Wei Zhang, Lisheng Chu
BACKGROUND: Brain tumors are one of the leading causes of epilepsy, and brain tumor-related epilepsy (BTRE) is recognized as the major cause of intractable epilepsy, resulting in huge treatment cost and burden to patients, their families, and society. Although optimal treatment regimens are available, the majority of patients with BTRE show poor resolution of symptoms. BTRE has a very complex and multifactorial etiology, which includes several influencing factors such as genetic and molecular biomarkers...
April 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38639892/surgical-management-of-large-lower-cranial-nerves-schwannomas-long-term-results-of-a-less-aggressive-resection-strategy
#16
JOURNAL ARTICLE
Lucas Troude, Yamaurys Esther Ogando, Anne Balossier, Guillaume Baucher, Jean Régis, Pierre-Hugues Roche
In an effort to reduce the high morbidity and life-threatening complications after radical resection in large schwannoma surgery, alternative strategies of nontotal resections have emerged. To evaluate the long term clinical and oncological outcome after lower cranial nerves (LCN) schwannoma surgery operated on with a cranial nerve-sparing technique. Single center retrospective cohort study of 8 consecutive patients harboring LCN schwannomas operated on between March 2005 and October 2021. The mean LCN schwannoma diameter was 33 mm (range 26-51)...
April 19, 2024: Neurosurgical Review
https://read.qxmd.com/read/38639853/central-nervous-system-embryonal-tumors-with-ewsr1-plagl1-rearrangements-reclassified-as-ini-1-deficient-tumors-at-relapse
#17
JOURNAL ARTICLE
Kevin J Bielamowicz, Mary Beth Littrell, Gregory W Albert, Lora S Parker, Sateesh Jayappa, Kenneth Aldape, Murat Gokden
PURPOSE: Central nervous system (CNS) embryonal tumors are a diverse group of malignant tumors typically affecting pediatric patients that recently have been better defined, and this paper describes evolution of a unique type of embryonal tumor at relapse. METHODS: Two pediatric patients with CNS embryonal tumors with EWSR1-PLAGL1 rearrangements treated at Arkansas Children's Hospital with histopathologic and molecular data are described. RESULTS: These two patients at diagnosis were classified as CNS embryonal tumors with EWSR1-PLAGL1 rearrangements based on histologic appearance and molecular data...
April 19, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38639785/the-role-of-annexins-in-central-nervous-system-development-and-disease
#18
REVIEW
Zachary B White, Sindhu Nair, Markus Bredel
Annexins, a group of Ca2+ -dependent phospholipid-binding proteins, exert diverse roles in neuronal development, normal central nervous system (CNS) functioning, neurological disorders, and CNS tumors. This paper reviews the roles of individual annexins (A1-A13) in these contexts. Annexins possess unique structural and functional features, such as Ca2+ -dependent binding to phospholipids, participating in membrane organization, and modulating cell signaling. They are implicated in various CNS processes, including endocytosis, exocytosis, and stabilization of plasma membranes...
April 19, 2024: Journal of Molecular Medicine: Official Organ of the "Gesellschaft Deutscher Naturforscher und Ärzte"
https://read.qxmd.com/read/38639614/identification-of-prognostic-markers-of-glioblastoma-through-bioinformatics-analysis
#19
JOURNAL ARTICLE
Jieying Wen, Haojie Zheng, Xi Yuan, Cuilan Huang, Xiaogang Yang, Zhiying Lin, Guanglong Huang
OBJECTIVE: Glioblastoma is the most common and aggressive type of the central nervous system cancers. Although radiotherapy and chemotherapy are used in the treatment of glioblastoma, survival rates remain unsatisfactory. This study aimed to explore differentially expressed genes (DEGs) based on the survival prognosis of patients with glioblastoma and to establish a model for classifying patients into different risk groups for overall survival. METHODS: DEGs from 160 tumor samples from patients with glioblastoma and 5 nontumor samples from other patients in The Cancer Genome Atlas database were identified...
April 18, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38639066/a-case-of-myxopapillary-ependymoma-with-predominant-giant-cell-morphology-a-rare-entity-with-comprehensive-genomic-profiling-and-review-of-literature
#20
Bryan Morales-Vargas, Hassan Saad, Daniel Refai, Matthew Schniederjan, Zied Abdullaev, Kenneth Aldape, Malak Abedalthagafi
In the evolving landscape of ependymoma classification, which integrates histological, molecular, and anatomical context, we detail a rare case divergent from the usual histopathological spectrum. We present the case of a 37-year-old man with symptomatic spinal cord compression at the L3-L4 level. Neuroradiological evaluation revealed an intradural, encapsulated mass. Histologically, the tumor displayed atypical features: bizarre pleomorphic giant cells, intranuclear inclusions, mitotic activity, and a profusion of eosinophilic cytoplasm with hyalinized vessels, deviating from the characteristic perivascular pseudorosettes or myxopapillary patterns...
April 19, 2024: Neuropathology: Official Journal of the Japanese Society of Neuropathology
keyword
keyword
65659
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.